France· FR:68971188
SLINDA 4 mg, comprimé pelliculé
A drospirenone product containing drospirénone, registered in France by EXELTIS SANTE. The same ATC class is registered in 13 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Drospirenone is registered in 13 of 19 countries.
Countries holding a registration under ATC G03AC10 (drospirenone), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 8 of them publish a price we can compare per daily dose
Drospirenone · ATC G03AC10
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- DROSPIRÉNONE
- Manufacturer
- EXELTIS SANTE
- Country
- France (FR)
- ATC code
- G03AC10
- ATC class
- Drospirenone
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
- cip133400930192740plaquette calendaire en PVC PVDC aluminium de 24 comprimés blancs (actifs) et 4 comprimés verts (placebo)
- cip1334009301927573 plaquettes calendaires en PVC PVDC aluminium de 24 comprimés blancs (actifs) et 4 comprimés verts (placebo)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
172 interactions on record for drospirenone.
Graded by severity as the source publishes them — 27 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Drospirenone · interactions on record
172 records
- 27 severe
- 143 moderate
- 2 minor
Most severe, free to view
- Tranexamic acidB02AA02severe
- GriseofulvinD01AA08severe
- GriseofulvinD01BA01severe
- KetoconazoleH02CA03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Drospirenone in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandSlinda 4.0 mg, FilmtablettenExeltis Suisse SA
- CzechiaZLYNDAExeltis Czech s.r.o., Praha
- SpainSLINDA 4 mg COMPRIMIDOS RECUBIERTOS CON PELICULAExeltis Healthcare S.L.
- FinlandSlindaExeltis Healthcare S.L.
- IrelandSlyndy 4 mg film-coated tabletsExeltis Healthcare S.L.
- IcelandSlindaExeltis Healthcare S.L.*
- NetherlandsSlinda 4 mg filmomhulde tablettenExeltis Healthcare S.L
- PolandSlindaExeltis Poland Sp. z o.o.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c55b682b-e5b5-44d4-8724-539075e40abe GET /v1/drugs/c55b682b-e5b5-44d4-8724-539075e40abe?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "68971188",
"date_amm": "2019-11-21",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "DROSPIRÉNONE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé et comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about drospirenone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.